Stanford University


Showing 1-10 of 47 Results

  • Ryan Christopher Padrez

    Ryan Christopher Padrez

    Clinical Professor, Pediatrics - General Pediatrics

    BioRyan is a Clinical Associate Professor of Pediatrics at Stanford University's Division of General Pediatrics. His primary clinical practices are at Gardner Packard Children's Health Center and Lucile Packard Children's Hospital. In addition to his work at Stanford, Ryan also serves as the Medical Director for The Primary School, a new integrated health and education model that serves low income children and families in East Palo Alto, CA. His work and leadership focuses on the intersection and reform of primary pediatric care and early childhood education. He works to integrate systems and promote models that ensure high quality care is accessible to all children.

    Ryan graduated from Stanford University with a BA in Human Biology and earned his MD at University of California, San Francisco (UCSF). He completed his pediatric residency at UCSF and participated in UCSF's Pediatric Leadership for the Underserved (PLUS) program. He went on to complete a chief resident year at The San Francisco General Hospital and Trauma Center.

  • Natalie Pageler

    Natalie Pageler

    Clinical Professor, Clinical Informatics
    Clinical Professor, Computational Medicine

    Current Research and Scholarly InterestsIn my administrative role, I oversee the development and maintenance of clinical decision support tools within the electronic medical record. These clinical decision support tools are designed to enhance patient safety, efficiency, and quality of care. My research focuses on rigorously evaluating--1) how these tools affect clinician knowledge, attitudes, and behaviors; and 2) how these tools affect clinical outcomes and efficiency of health care delivery.

  • Robertson Parkman

    Robertson Parkman

    Other Teaching Staff-Hourly, Pediatrics - Stem Cell Transplantation

    BioMy principal research interests have been the assessment of the immunological consequences of hematopoietic stem cell transplantation including both acute and chronic graft versus host disease and immune reconstitution and the use of hematopoietic stem cell transplantation to treat genetic diseases. My laboratory was the first to suggest that chronic graft versus host disease was an autoimmune disease directed at histocompatibility antigens shared by donors and recipients. The observation leaded to the assessment of the role of thymic dysfunction in the pathogenesis of chronic graft versus host disease. As a pediatric immunologist I have investigated the role of hematopoietic stem cell transplantation initially in the treatment of primary immune deficiency diseases and later the treatment of metabolic diseases, which lead to my involvement in the early gene transfer clinical trials.

  • Sonia Partap

    Sonia Partap

    Clinical Professor, Pediatric Neurology
    Clinical Professor (By courtesy), Neurosurgery
    Clinical Professor (By courtesy), Pediatrics

    Current Research and Scholarly InterestsMy research interests involve the epidemiology, treatment and diagnosis of pediatric and young adult brain tumors. I am also interested in long-term neurologic effects and designing clinical trials to treat brain and spinal cord tumors.

  • Anca M. Pasca, MD

    Anca M. Pasca, MD

    Assistant Professor of Pediatrics

    Current Research and Scholarly InterestsI am a physician-scientist, neonatologist, and stem cell biologist whose research focuses on understanding mechanisms of human brain development, neuroinflammation, and neurological injury using patient-derived stem cell models.
    I was among the early pioneers of three-dimensional human cortical organoid technologies and contributed to development of foundational protocols for generating region-specific human brain organoids from pluripotent stem cells. My work helped establish the feasibility of modeling human brain development and disease using stem cell-derived tissues and has contributed to the widespread adoption of organoid technologies across neuroscience, regenerative medicine, and translational research.
    A major focus of my laboratory is the development of increasingly sophisticated multicellular organoid and assembloid systems that incorporate diverse neuronal and glial populations to model complex human brain circuitry and disease processes. We integrate stem cell biology, organoid engineering, CRISPR-based genome editing, single-cell transcriptomics, epigenomics, high-content imaging, and computational approaches to identify disease mechanisms and therapeutic targets. These technologies have been applied to studies of hypoxic brain injury, 22q11.2 deletion syndrome, Trisomy 21 (Down Syndrome), Trisomy 18, narcolepsy, Alzheimer's and Parkinson's Disease.